Delivery Order SPE2DB20D3303-SPE2DB25FA1PD
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $4,741.71 to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mL pharmaceutical supplies. The contract is a firm fixed price delivery order with an ultimate completion date of July 28, 2025, and represents a non-set-aside competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,132.95 to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mL, a pharmaceutical product for immunological treatment. The contract is a firm fixed price delivery order with no set-aside designation, awarded on July 24, 2025, with an ultimate completion date of July 25, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, performed this work at its corporate office location. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $5,543.70 to AmerisourceBergen Drug Corp for the supply of Humira Pen 40 mg/0.8 mls, a pharmaceutical product used to treat inflammatory conditions. This competitively awarded, firm fixed-price contract was issued on July 22, 2025, with an ultimate completion date of July 23, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $16,204.30 to AmerisourceBergen Drug Corp for the supply of HUMIRA (CF) Pen 40 mg/0.4 mL, a pharmaceutical product used in the treatment of autoimmune conditions. This firm fixed-price delivery order, issued on July 22, 2025, with an ultimate completion date of July 23, 2025, represents a competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania—the...
- The Defense Logistics Agency awarded a delivery order valued at $12,864.94 to AmerisourceBergen Drug Corp for the supply of HUMIRA (CF) Pen 40 mg/0.4 mL, a pharmaceutical product used in the treatment of autoimmune conditions. The contract was awarded on July 18, 2025, with an ultimate completion date of July 21, 2025, and utilizes firm fixed pricing with no set-aside designation. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $3,776.50 firm fixed-price delivery order to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mls, with an ultimate completion date of July 23, 2025. This competitive award, issued on July 22, 2025, carries no set-aside designation and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. The performance...
- The Defense Logistics Agency awarded a $3,828.03 delivery order to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mL pharmaceutical supplies on July 21, 2025, with an ultimate completion date of July 22, 2025. This firm fixed-price, non-set-aside contract represents a child delivery order under AmerisourceBergen's broader Indefinite Delivery Contract vehicle with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The supplies will be...
- The Defense Logistics Agency awarded a $8,685.95 delivery order to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mls, a pharmaceutical product used in the treatment of inflammatory diseases. This non-set-aside, firm fixed-price contract was awarded on July 18, 2025, with an ultimate completion date of July 21, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a routine procurement action under the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mL pharmaceutical supplies, valued at $4,531.80 under a firm fixed price contract. The award, issued on July 23, 2025, with an ultimate completion date of July 24, 2025, represents a non-competitive delivery order executed without set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform all work at its corporate office location in the...
- The Defense Logistics Agency awarded a $17,115.36 delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of HUMIRA Pen 40 mg/0.8 mL injectable medication. This contract represents a firm fixed price delivery order with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 25, 2025. As a child order, this award leverages...
- SPE2DB20D3303Indefinite Delivery Contract
- SPE2DB20D3303-SPE2DB25FA1PDDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $24,777.17 to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mL pharmaceutical products. This firm fixed-price delivery order, awarded on July 21, 2025, with an ultimate completion date of July 22, 2025, represents a non-competitive set-aside order fulfilling federal medical procurement requirements. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, which serves as the company's headquarters and primary distribution hub for federal medical supply operations. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9 billion prime vendor agreement running through December 2026 that enables comprehensive pharmaceutical and medical supply support for military healthcare programs worldwide. AmerisourceBergen is a major pharmaceutical distributor providing critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, and specialized medical supplies to support Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The company's extensive federal contract portfolio demonstrates its established capability to meet competitive procurement requirements and fulfill the medical supply needs of the defense and veteran healthcare systems at scale.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $24.8k | 7/21/25 |